W

Western Sky Medical Research | El Paso, TX

Research site

(Unclaimed)

Location

2121 Wyoming Avenue, El Paso, Texas, United States of America

Site insights

Top conditions

Top treatments

Ciclesonide

Remibrutinib

azelastine hydrochloride

CNP-201

LOU064

RPT193

HFA

Formoterol

Omalizumab

Fluticasone Propionate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 34 total trials

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

The purpose of this extension study is to collect long-term efficacy, safety and tolerability data on remibrutinib in a selected group of participant...

Enrolling

Chronic Spontaneous Urticaria

Drug: LOU064 (blinded)

Drug: LOU064 (open label)

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma (AIRCULES)

This is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, saf...

Enrolling

Asthma

Drug: Placebo

Drug: Lunsekimig

Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

This clinical research study investigates the safety and tolerability of a peanut SLIT-tablet.

Enrolling

Peanut Allergy

Biological: Peanut SLIT-tablet

Locations recently updated

Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

A study to evaluate the safety, efficacy and tolerability of remibrutinib at three doses versus placebo in adult participants who have a confirmed al...

Enrolling

Allergy, Peanut

Drug: placebo

Drug: remibrutinib